A Phase III,Randomized, Double-blind, Propofol-controlled, Parallel-design, Multi-center Study Evaluating The Efficacy and Safety of HSK3486 for Sedation or Anesthesia in Patients Undergoing Colonoscopy and Gastroscopy
Phase of Trial: Phase III
Latest Information Update: 08 Jul 2019
Price : $35 *
At a glance
- Drugs HSK 3486 (Primary) ; Propofol
- Indications Anaesthesia
- Focus Registrational; Therapeutic Use
- Sponsors Sichuan Haisike Pharmaceutical
- 03 Apr 2019 Status changed from recruiting to completed.
- 17 Feb 2019 Planned primary completion date changed from 1 Jan 2019 to 1 Mar 2019.
- 19 Oct 2018 Status changed from not yet recruiting to recruiting.